Medical Research News

RSS

Cardiovascular risks for excessive endurance training highlighted

Ironman triathlons, ultramarathons, and even marathons are potentially associated with a risk for adverse cardiovascular effects.

19 Jun 2012

Improved CT angiography protocols minimize radiation exposure

Refinements to coronary computed tomography angiography practices can significantly reduce the radiation dose associated with imaging, demonstrates research from Massachusetts General Hospital in Boston, USA.

19 Jun 2012

Bisphosphonate benefit for breast cancer yet to be proven

Older patients with breast cancer may benefit from adjuvant treatment with oral bisphosphonates, but further studies are needed before general application in the breast cancer population, say researchers.

19 Jun 2012

Hospital noises disturb sleep

Common hospital noises such as human conversations, paging systems, intravenous alarms sounding, and doors closing easily disturb patients’ sleep, according to US study results.

19 Jun 2012

HCV suppression reduces liver damage

Profound suppression of the hepatitis C virus reduces long-term hepatic inflammation and fibrosis even in patients who do not achieve a sustained virologic response, research demonstrates.

19 Jun 2012

Home BP monitoring ‘could help guide dosing, titration’

Researchers report that home blood pressure monitoring provides a reliable indicator of blood pressure control in elderly patients.

19 Jun 2012

UK walking guidelines ‘not up to speed’

The current assumed pedestrian walking speed of 1.2 m per second should be revised, say researchers whose findings show that the average UK resident over the age of 65 years does not walk at this pace.

19 Jun 2012

Hyaluronic acid injections ‘discouraged’ for knee osteoarthritis

Intra-articular injections of hyaluronic acid offer a small, clinically irrelevant decrease in osteoarthritis knee pain at the risk for serious adverse events, suggest the results of a review and meta-analysis.

19 Jun 2012

Study points to unexplored coding potential within the genome

Sequencing the human genome was just the first step. The next challenge is of the kind that makes history: to decode the genome, and understand how the information needed to construct a human being can be packaged into a single molecule.

19 Jun 2012

AFAR announces new Collaborative Research Awards Program in Alzheimer's Disease

The American Federation for Aging Research (AFAR) announced today a new grant program that will support collaboration among young scientists from different scientific disciplines, to help tackle some of the most vexing questions about Alzheimer's disease.

19 Jun 2012

Improving outcomes for children with acquired brain injuries a significant challenge

Outcomes for children with brain injury acquired during childhood are difficult to predict and vary significantly, states an analysis of evidence on the topic published in CMAJ (Canadian Medical Association Journal).

19 Jun 2012

Program to correct problematic research practices

A $500,000 grant to Saint Louis University's Gnaegi Center for Health Care Ethics will fund the first ever remediation program to aid institutions when they discover researchers who have engaged in wrongdoing or unprofessional behavior. The Restoring Professionalism and Integrity in Research (RePAIR) program is expected to launch in November 2012.

19 Jun 2012

Legalization of medical marijuana does not increase drug usage among high school students

While marijuana use by teens has been increasing since 2005, an analysis of data from 1993 through 2009 by economists at three universities has found no evidence to link the legalization of medical marijuana to increased use of the drug among high school students.

19 Jun 2012

New patent filed for VAC-3S, an immunotherapy for treating HIV infections

InnaVirVax, a biopharmaceutical company specialized in the research and development of therapeutic and diagnostic innovations focused on immune dysregulation, announced today that a new European patent application has been filed on VAC-3S, a “first-in-class” immunotherapy for the treatment of HIV infections.

19 Jun 2012

Cheaper drug to treat wet AMD increases risk of serious eye inflammation

A Queen's University study of two eye drugs used to treat wet Age-related Macular Degeneration (AMD) has determined the cheaper of the two could lead to eye inflammation, a potentially blinding adverse effect.

19 Jun 2012

LDL particles may be a more accurate measure of early-stage atherosclerosis

LipoScience, Inc., today announced publication of a clinical study in the current issue of Atherosclerosis suggesting that low density lipoprotein (LDL) particles may be a more accurate measure of early-stage (subclinical) atherosclerosis than LDL cholesterol among retired National Football League (NFL) players.

19 Jun 2012

FORMA, TD2 leverage synergistic capabilities to jointly develop transformative cancer therapies

FORMA Therapeutics and TGen Drug Development (TD2) today announced an agreement to jointly develop transformative cancer therapies, leveraging the synergistic capabilities of both organizations.

19 Jun 2012

New clinical data for ZEVALIN Injection for intravenous use presented at 17th EHA Congress

Spectrum Pharmaceuticals, Inc., a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology and hematology, today announced new clinical data presented in an oral presentation for ZEVALIN (ibritumomab tiuxetan) Injection for intravenous use at the 17th Congress of the European Hematology Association (EHA).

19 Jun 2012

Psychological distress associated with higher risk of death from stroke

Psychological distress was associated with a higher risk of death from stroke, according to a study published in CMAJ (Canadian Medical Association Journal).

19 Jun 2012

Pediatric treatment regime for ALL patients improves chances of long-term survival

Acute lymphoblastic leukemia (ALL), usually found in pediatric patients, is far more rare and deadly in adolescent and adult patients. According to the National Marrow Donor Program, child ALL patients have a higher than 80 percent remission rate, while the recovery rate for adults stands at only 40 percent.

18 Jun 2012